Fair Value Measurements (Fair Value Hierarchy By Level) (Details) - USD ($) $ in Millions			12 Months Ended
	Mar. 01, 2017	Feb. 10, 2016	Jun. 30, 2017	Jun. 30, 2016	Oct. 03, 2016	Jan. 19, 2016	Jun. 30, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Discount Rate			1.00%
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value				$ 5.2			$ 7.3
Business Combination, Contingent Consideration, Liability			$ (18.0)	(5.2)
Derivative, Fair Value, Net			0.7	(1.3)
Foreign Currency Exchange Contracts			5.7
Foreign Currency Contract, Asset, Fair Value Disclosure				(5.3)
Fair Value, Net Asset (Liability)			(11.6)	(11.8)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases			$ 11.5	4.5
Fair Value Assumptions, Weighted Average Volatility Rate			38.00%
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability			$ 0.0	0.0
Derivative, Fair Value, Net			0.0	0.0
Foreign Currency Exchange Contracts			0.0
Foreign Currency Contract, Asset, Fair Value Disclosure				0.0
Fair Value, Net Asset (Liability)			0.0	0.0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability			0.0	0.0
Derivative, Fair Value, Net			0.7	(1.3)
Foreign Currency Exchange Contracts			5.7
Foreign Currency Contract, Asset, Fair Value Disclosure				(5.3)
Fair Value, Net Asset (Liability)			6.4	(6.6)
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability			(18.0)	(5.2)
Derivative, Fair Value, Net			0.0	0.0
Foreign Currency Exchange Contracts			0.0
Foreign Currency Contract, Asset, Fair Value Disclosure				0.0
Fair Value, Net Asset (Liability)			(18.0)	(5.2)
Forward Contracts [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value			0.0	$ 0.0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases			40.0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings			(20.7)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Issuances			$ (19.3)
Health Advances Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High						$ 15.8
Fair Value Inputs, Discount Rate			1.00%
Business Combination, Contingent Consideration, Liability						$ (4.5)
Fair Value Assumptions, Weighted Average Volatility Rate		24.00%
Fair Value, Measurement Inputs, Disclosure [Text Block]			Approximately 2 years
ExecuPharm Inc. [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High					$ 20.0
Fair Value Inputs, Discount Rate			1.00%
Business Combination, Contingent Consideration, Liability					$ (9.4)
Fair Value Assumptions, Weighted Average Volatility Rate		25.00%
Fair Value, Measurement Inputs, Disclosure [Text Block]			12 months
TMAC [Member] [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 11.0
Fair Value Inputs, Discount Rate			2.00%
Business Combination, Contingent Consideration, Liability	$ (2.1)
Fair Value Assumptions, Weighted Average Volatility Rate	25.00%
Fair Value, Measurement Inputs, Disclosure [Text Block]			2.5 years